Brazilian aHUS & TMA Study Group

Grupo de estudos brasileiro de SHUa &  MAT

atypical Hemolytic Uremic Syndrome Brazil

Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
de Holanda MI1, Pôrto LC2, Wagner T3, Christiani LF3, Palma LMP4.

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome.
Palma LM1, Langman CB2.

Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J1, Haller H2, Mannucci PM3, Nangaku M4, Praga M5, Rodriguez de Cordoba S6.